CXCR4 and osteosarcoma: Kato et al. indicated that the use of the chimeric anti-TNF-α mAb, infliximab inhibited pulmonary metastasis of osteosarcoma in the mouse model by suppressing the expression of CXC chemokine receptor 4 (CXCR4) and Rho small GTPase protein [41].